| Filed On | Filing |
|---|---|
| 23 Oct 2026 | SCHEDULE 13G/A |
| 22 Oct 2026 |
8-K: Entry into a Material Definitive Agreement; Material Modifications to Rights of Security Holders
Effective as of October 21, 2026, Lucid Diagnostics Inc. (the “Lucid Diagnostics”), a subsidiary of PAVmed Inc. (the “Company”), entered into subscription agreements (each, a “Subscription Agreement”) with certain accredited investors (c... |
| 10 Sep 2026 | 424B5 |
| 10 Sep 2026 |
8-K: Entry into a Material Definitive Agreement
On September 9, 2026, PAVmed Inc. (the “Company”) entered into a Sales Agreement (the “Agreement”) with A.G.P./Alliance Global Partners, as sales agent (the “Agent”), pursuant to which the Company may offer and sell, from time to time th... |
| 14 Aug 2026 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 | FORM 10-Q |
| 30 Jul 2026 | S-8 |
| 24 Jun 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders |
| 15 May 2026 | SCHEDULE 13G |
| 15 May 2026 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 14 May 2026 | SCHEDULE 13G |
| 14 May 2026 | FORM 10-Q |
| 11 May 2026 | SCHEDULE 13G/A |
| 30 Apr 2026 | Proxy statement: annual meeting on June 24, 2026 |
| 30 Apr 2026 | DEFA14A |
| 30 Apr 2026 | ARS |
| 29 Apr 2026 | EFFECT |
| 29 Apr 2026 | 424B3 |
| 27 Apr 2026 | CORRESP |
Loading...
